Merck KGaA's Allergopharma opens production facility

By Gareth Macdonald

- Last updated on GMT


Related tags Asthma Immune system Merck kgaa

Merck KGaA has opened a €42m production facility in Reinbek near Hamburg, Germany.

The 6,000sqm facility​ will be operated by Merck’s subsidiary Allergopharma and will focus on the production of treatments for allergy, including allergic asthma and hay fever.

Merck has been constructing the facility since 2013. At the time​ the firm said the facility would support expansion into new markets including China.

This was reiterated by COO Simon Sturge who said on Thursday that the facility is part of a "global expansion, and will support our growing business in the allergy market place.”

Related news

Related products

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 04-May-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Follow us


View more